Abdulla A. Damluji/X
Nov 18, 2025, 08:52
Aspirin or P2Y12 Monotherapy?
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
Very nice review.”
Stay informed with Hemostasis Today.
-
Mar 11, 2026, 23:05Ney Carter Borges: A Safety Advantage of Apixaban over Rivaroxaban Without Clear Superiority
-
Mar 11, 2026, 22:01The Results of Landmark COBRRA Trial in Acute VTE Management – ISTH
-
Mar 11, 2026, 21:19Peter Antevy: EMS Rarely Suspects Pediatric Stroke And It’s Costing Kids Time
-
Mar 11, 2026, 19:24Robert Sidonio: Prophylaxis with Wilate and The WIL-31 Study Results
-
Mar 11, 2026, 18:42Annette Logan-Parker: A Hemophilia B Breakthrough – From Weekly Infusions to One Treatment
-
Mar 11, 2026, 18:27Cesar Garrido and Lackram Bodoe Are Advancing WFH Partnerships in Trinidad and Tobago
-
Mar 11, 2026, 18:14Aloke Finn: Silent Plaque Rupture and Healing in Coronary Artery Disease
-
Mar 11, 2026, 17:23Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
-
Mar 11, 2026, 17:12Shubham Misra: Proteomic Biomarkers for Acute Stroke Subtype Classification